Postgrad LIVE! Study Fairs

Bristol

University of Leeds Featured PhD Programmes
University of Portsmouth Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Huddersfield Featured PhD Programmes
University of Leeds Featured PhD Programmes

ECLIPSE: Effect of carnitine on Liver steatosis, Insulin sensitivity, Plasma glucose, Skeletal muscle metabolism and Energetics - a pilot study


Project Description

This ambitious project unites institutional research priorities in translational imaging, liver disease and musculoskeletal health. Through cross-cutting collaborations between the Schools of Medicine, Life Sciences and Physics, we will employ MR spectroscopy in combination with the euglycaemic hyperinsulinaemic clamp technique to explore the pathophysiology of non-alcoholic fatty liver disease (NAFLD). The study will hinge upon use of sophisticated MRS methods to quantitate the impact of chronic dietary supplementation with L-carnitine on hepatic and intramyocellular carnitine moieties, lipid content and hepatic mitochondrial metabolism.



NAFLD presents a growing public health and economic challenge and is the leading cause of chronic liver disease in high-income economies. As there is no licensed pharmacological treatment for this condition, its clinical and economic burden are projected to rise dramatically in coming decades. L-carnitine is a naturally occurring amine located primarily in skeletal muscle tissue that plays a central role in mitochondrial fat oxidation. Accordingly, increasing muscle carnitine content, by targeting insulin mediated carnitine transport, has been shown to augment muscle fat oxidation and gene networks regulating this process in healthy volunteers. We hypothesise that increasing muscle carnitine content in NAFLD using a dietary mediated approach will increase muscle fat oxidation and reduce intramyocellular muscle lipid content, and secondary to this will reduce muscle and hepatic insulin resistance and hepatic fat content, thereby augmenting hepatic mitochondrial ATP flux. We will therefore highlight L-carnitine as a broadly-applicable and safe potential treatment option in a NAFLD population.



This study affords abundant opportunities for development and validation of novel MR spectroscopic methods, including:

Refining and validating saturation transfer 31P-MRS methodology at 3T to quantitatively determine hepatic ATP flux in NAFLD.

Developing 1H-MRS methods to quantify carnitine moieties in muscle tissue. This will develop and validate a non-invasive protocol for determination of muscle free carnitine, as well as acylcarnitine moieties, by comparison against biopsy-determined values.

Use of 1H-MRS at 3T to quantify intra- and extra- myocellular lipid fraction and determine its relationship to tissue-specific and whole-body insulin resistance.

Advanced 7T 1H-MRS muscle imaging, proton spectroscopy and IMCL/EMCL lipid quantification.



Each of these dimensions will add to the quality and depth of precision imaging capabilities at the University of Nottingham, enhancing its strategic value and enduring applicability across research priority areas worldwide. The project will provide excellent training within a multidisciplinary team and address the obvious skills gap in the application of MR spectroscopy in metabolic disease.

The project is in an area of priority for NIHR Nottingham Biomedical Research centre with two senior supervisors from Gastrointestinal and Liver disorder theme and musculoskeletal theme. This will permit the candidate to be involved in translational research and participate in N-Trans programme.



This is an excellent research opportunity, as the successful candidate will be exposed to high quality research in an environment where they will interact on a day-to-day basis with clinicians, academic research staff, postdoctoral fellows and other PhD students. This experimental and philosophical approach will produce the highly skilled, integrative translational scientist that is acutely required to meet research needs. Applicants must have a minimum of UK 2.1 honours degree (or equivalent) in physics or a related area (e.g. mathematics, chemistry or computer science, depending on skills and interests).

Funding Notes

Deadline for applications is 25 February 2019, with interviews for applicants to take place between 4 and 8 March 2019
Applicants for the Precision Imaging PhD programme should have at least a 2:1 degree, or equivalent, in a project-relevant discipline. Funding is only available for UK and EU students.

Related Subjects

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully





FindAPhD. Copyright 2005-2019
All rights reserved.